Molecular subtyping, prognostic evaluation, and tumor immune microenvironment heterogeneity in intrahepatic cholangiocarcinoma based on epithelial-mesenchymal transition and mitophagy-related genes
Background Intrahepatic cholangiocarcinoma (ICC) is a highly aggressive malignancy with a dismal prognosis, yet effective prognostic biomarkers and therapeutic targets remain scarce. Both epithelial-mesenchymal transition (EMT) and mitophagy are known to drive tumor progression and therapy resistance, but their synergi...